For the Inventor, By the Inventor

Enter assignee name

Pittsboro, NC, United States of America

Biolex Therapeutics, Inc.

USPTO Granted Patents = 16

CIPO Patents = 1

EPO Patents = 6

Forward Citations = 46

Loading Chart...

Loading Chart...

23 inventors (with patents filed for the assignee):

Lynn F Dickey (10 out of 13 patents)

Kevin Cox (8 out of 11 patents)

John Gasdaska (6 out of 7 patents)

4. Charles G Peele (5 out of 7 patents)

5. Anne Chantal Bechet (3 out of 3 patents)

6. Riemke Van Dijkhuizen-Radersma (3 out of 3 patents)

7. Martin Stigter (3 out of 4 patents)

8. Jeroen Mattijs Bezemer (3 out of 8 patents)

9. David Spencer (3 out of 3 patents)

10. Xiaowei Wang (2 out of 2 patents)

11. Joyce Pritchard (1 out of 16 patents)

12. Xuan Guo (1 out of 4 patents)

13. David Gelvin Spencer, Jr (1 out of 1 patent)

14. John Elliott Humphries (1 out of 1 patent)

15. Leonardus Gerardus Jozef De Leede (1 out of 1 patent)

16 patents: Sort by Forward Citations

1. 8394384 - Recombinant avian influenza vaccine and uses thereof (2013-03-12),

2. 8182803 - C-terminally truncated interferon alpha variants (2012-05-22),

3. 8163307 - Controlled release compositions for interferon based PEGT/PBT block copolymers and method for preparation thereof (2012-04-24),

4. 8137661 - Controlled release interferon drug products and treatment of HCV infections using same (2012-03-20),

5. 8034916 - [object Object] (2011-10-11),

6. 8022270 - Expression of biologically active polypeptides in duckweed (2011-09-20),

7. 8017836 - Expression of plasminogen and microplasminogen in duckweed (2011-09-13),

8. 7959910 - C-terminally truncated interferon alpha variants (2011-06-14),

9. 7915483 - C-terminally truncated interferon (2011-03-29),

10. 7884264 - Compositions and methods for inhibition of fucosyltransferase and xylosyltransferase expression in duckweed plants (2011-02-08),

11. 7867518 - Controlled release compositions for interferon based on PEGT/PBT block copolymers and method for preparation thereof (2011-01-11),

12. 7736674 - Controlled release compositions for interferon based on PEGT/PBT block copolymers (2010-06-15),

13. 7709699 - Use of duckweed in high throughput screening (2010-05-04),

14. 7659445 - Expression of plasminogen and microplasminogen in duck weed (2010-02-09),

15. 7632983 - Expression of monoclonal antibodies in duckweed (2009-12-15),

Biolex Therapeutics, Inc. is a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and life-threatening diseases. With a strong emphasis on utilizing its proprietary LEX System™ platform, Biolex aims to advance the discovery and production of therapeutic proteins. Through strategic collaborations and partnerships, Biolex is dedicated to delivering innovative, safe, and effective treatment options to patients worldwide.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

16 Patents

#3 in Pittsboro, NC

#433 in North Carolina

#19,327 in US

#36,703 in the World

Pittsboro, NC, United States of America

Biolex Therapeutics, Inc.

Forward Citations = 46

23 inventors:

Lynn F Dickey (10 out of 13 patents)

Kevin Cox (8 out of 11 patents)

John Gasdaska (6 out of 7 patents)

4. Charles G Peele (5 out of 7 patents)

5. Anne Chantal Bechet (3 out of 3 patents)

Please report any incorrect information to support@idiyas.com

Loading…